Cargando…
S247: ADDING RUXOLITINIB AND DECITABINE TO BU/CY CONDITIONING REGIMENS TO PROPHYLAXIS POST-TRANSPLANT RELAPSE IN HIGH-RISK AML IS SAFE AND EFFECTIVE: A PROSPECTIVE, PHASE II STUDY
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428308/ http://dx.doi.org/10.1097/01.HS9.0000967900.54514.e6 |
| _version_ | 1785090436655742976 |
|---|---|
| author | Wei, Yujun Qian, Kun Wang, Lili LI, Fei Wang, Nan Peng, Bo Wen, Yanan Wang, Lu Xu, Lingmin Jin, Xiangshu Dou, Liping Liu, Dai-Hong |
| author_facet | Wei, Yujun Qian, Kun Wang, Lili LI, Fei Wang, Nan Peng, Bo Wen, Yanan Wang, Lu Xu, Lingmin Jin, Xiangshu Dou, Liping Liu, Dai-Hong |
| author_sort | Wei, Yujun |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428308 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104283082023-08-17 S247: ADDING RUXOLITINIB AND DECITABINE TO BU/CY CONDITIONING REGIMENS TO PROPHYLAXIS POST-TRANSPLANT RELAPSE IN HIGH-RISK AML IS SAFE AND EFFECTIVE: A PROSPECTIVE, PHASE II STUDY Wei, Yujun Qian, Kun Wang, Lili LI, Fei Wang, Nan Peng, Bo Wen, Yanan Wang, Lu Xu, Lingmin Jin, Xiangshu Dou, Liping Liu, Dai-Hong Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428308/ http://dx.doi.org/10.1097/01.HS9.0000967900.54514.e6 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Oral Sessions Wei, Yujun Qian, Kun Wang, Lili LI, Fei Wang, Nan Peng, Bo Wen, Yanan Wang, Lu Xu, Lingmin Jin, Xiangshu Dou, Liping Liu, Dai-Hong S247: ADDING RUXOLITINIB AND DECITABINE TO BU/CY CONDITIONING REGIMENS TO PROPHYLAXIS POST-TRANSPLANT RELAPSE IN HIGH-RISK AML IS SAFE AND EFFECTIVE: A PROSPECTIVE, PHASE II STUDY |
| title | S247: ADDING RUXOLITINIB AND DECITABINE TO BU/CY CONDITIONING REGIMENS TO PROPHYLAXIS POST-TRANSPLANT RELAPSE IN HIGH-RISK AML IS SAFE AND EFFECTIVE: A PROSPECTIVE, PHASE II STUDY |
| title_full | S247: ADDING RUXOLITINIB AND DECITABINE TO BU/CY CONDITIONING REGIMENS TO PROPHYLAXIS POST-TRANSPLANT RELAPSE IN HIGH-RISK AML IS SAFE AND EFFECTIVE: A PROSPECTIVE, PHASE II STUDY |
| title_fullStr | S247: ADDING RUXOLITINIB AND DECITABINE TO BU/CY CONDITIONING REGIMENS TO PROPHYLAXIS POST-TRANSPLANT RELAPSE IN HIGH-RISK AML IS SAFE AND EFFECTIVE: A PROSPECTIVE, PHASE II STUDY |
| title_full_unstemmed | S247: ADDING RUXOLITINIB AND DECITABINE TO BU/CY CONDITIONING REGIMENS TO PROPHYLAXIS POST-TRANSPLANT RELAPSE IN HIGH-RISK AML IS SAFE AND EFFECTIVE: A PROSPECTIVE, PHASE II STUDY |
| title_short | S247: ADDING RUXOLITINIB AND DECITABINE TO BU/CY CONDITIONING REGIMENS TO PROPHYLAXIS POST-TRANSPLANT RELAPSE IN HIGH-RISK AML IS SAFE AND EFFECTIVE: A PROSPECTIVE, PHASE II STUDY |
| title_sort | s247: adding ruxolitinib and decitabine to bu/cy conditioning regimens to prophylaxis post-transplant relapse in high-risk aml is safe and effective: a prospective, phase ii study |
| topic | Oral Sessions |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428308/ http://dx.doi.org/10.1097/01.HS9.0000967900.54514.e6 |
| work_keys_str_mv | AT weiyujun s247addingruxolitinibanddecitabinetobucyconditioningregimenstoprophylaxisposttransplantrelapseinhighriskamlissafeandeffectiveaprospectivephaseiistudy AT qiankun s247addingruxolitinibanddecitabinetobucyconditioningregimenstoprophylaxisposttransplantrelapseinhighriskamlissafeandeffectiveaprospectivephaseiistudy AT wanglili s247addingruxolitinibanddecitabinetobucyconditioningregimenstoprophylaxisposttransplantrelapseinhighriskamlissafeandeffectiveaprospectivephaseiistudy AT lifei s247addingruxolitinibanddecitabinetobucyconditioningregimenstoprophylaxisposttransplantrelapseinhighriskamlissafeandeffectiveaprospectivephaseiistudy AT wangnan s247addingruxolitinibanddecitabinetobucyconditioningregimenstoprophylaxisposttransplantrelapseinhighriskamlissafeandeffectiveaprospectivephaseiistudy AT pengbo s247addingruxolitinibanddecitabinetobucyconditioningregimenstoprophylaxisposttransplantrelapseinhighriskamlissafeandeffectiveaprospectivephaseiistudy AT wenyanan s247addingruxolitinibanddecitabinetobucyconditioningregimenstoprophylaxisposttransplantrelapseinhighriskamlissafeandeffectiveaprospectivephaseiistudy AT wanglu s247addingruxolitinibanddecitabinetobucyconditioningregimenstoprophylaxisposttransplantrelapseinhighriskamlissafeandeffectiveaprospectivephaseiistudy AT xulingmin s247addingruxolitinibanddecitabinetobucyconditioningregimenstoprophylaxisposttransplantrelapseinhighriskamlissafeandeffectiveaprospectivephaseiistudy AT jinxiangshu s247addingruxolitinibanddecitabinetobucyconditioningregimenstoprophylaxisposttransplantrelapseinhighriskamlissafeandeffectiveaprospectivephaseiistudy AT douliping s247addingruxolitinibanddecitabinetobucyconditioningregimenstoprophylaxisposttransplantrelapseinhighriskamlissafeandeffectiveaprospectivephaseiistudy AT liudaihong s247addingruxolitinibanddecitabinetobucyconditioningregimenstoprophylaxisposttransplantrelapseinhighriskamlissafeandeffectiveaprospectivephaseiistudy |